You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Treatment Naive

Showing 1 - 25 of 5,931
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Twin Vaginal Delivery Skills Trial in Pescara (twin vaginal delivery simulation)

Recruiting
  • Twin Vaginal Delivery Skills
  • twin vaginal delivery simulation
  • Pescara, Italia, Italy
    Claudio Celentano
Nov 6, 2023

Vitamin D Deficiency, Peripheral Neuropathy Trial (Vitamin D)

Not yet recruiting
  • Vitamin D Deficiency
  • Peripheral Neuropathy
  • Vitamin D
  • (no location specified)
May 2, 2023

Prostate Cancer Trial in Taoyuan (Multiparametric magnetic resonance imaging (mpMRI))

Active, not recruiting
  • Prostate Cancer
  • Multiparametric magnetic resonance imaging (mpMRI)
  • Taoyuan, Taiwan
    Li-Jen Wang
Nov 9, 2023

Advanced Solid Tumor Trial (INCB099280)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
May 19, 2023

Sinus Rhythm Mapping in Pulmonary Vein Isolation Naive Atrial

Recruiting
  • Atrial Fibrillation
  • AI-enabled ECG score for Atrial Fibrillation (DNN score)
  • Atrial voltage map in sinus rhythm
  • Genk, Limburg, Belgium
    Ziekenhuis Oost-Limburg
Oct 19, 2023

GHD Trial in Fort Worth (GenSci004, Genotropin)

Not yet recruiting
  • GHD
  • Fort Worth, Texas
    Cook Childrens
Aug 24, 2023

Ustekinumab Among Bio-naive Crohn's Disease in China

Not yet recruiting
  • Crohn Disease
  • Hangzhou, Zhejiang, China
  • +2 more
Oct 9, 2023

Diffuse Large B Cell Lymphoma Trial in Shanghai (Zanubrutinib, Polatuzumab Vedotin, Rituximab)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Zanubrutinib, Polatuzumab Vedotin, Rituximab
  • Shanghai, Shanghai, China
    Zhongshan Hospital，Fudan University
Jul 10, 2023

Schizophrenia Trial in Changsha (transcranial magnetic stimulation, sham stimulation)

Active, not recruiting
  • Schizophrenia
  • transcranial magnetic stimulation
  • sham stimulation
  • Changsha, Hunan, China
    Central South University
Nov 16, 2022

Diffuse Large B Cell Lymphoma Trial in Suzhou (Rituximab, Orelabrutinib, Pomalidomide)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Suzhou, Jiangsu, China
    the First Affiliated Hospital of Soochow University
Apr 10, 2023

Myelofibrosis, Moderate Thrombocytopenia Trial (Selinexor)

Not yet recruiting
  • Myelofibrosis
  • Moderate Thrombocytopenia
  • (no location specified)
Jul 31, 2023

Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive

Recruiting
  • Non Muscle Invasive Bladder Cancer
  • N803 plus Bacillus Calmette-Guerin (BCG)
  • Honolulu, Hawaii
    Island Urology
Aug 7, 2023

Severe Aplastic Anemia Trial run by the NHLBI (Eltrombopag, Cyclosporine, Horse-Anti-thymocyte-Globulin)

Recruiting
  • Severe Aplastic Anemia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 27, 2023

Hiv, HIV-1-infection Trial in Buenos Aires (Lamivudine 300 MG, Emtricitabine / Tenofovir Disoproxil Pill)

Active, not recruiting
  • Hiv
  • HIV-1-infection
  • Lamivudine 300 MG
  • Emtricitabine / Tenofovir Disoproxil Pill
  • Buenos Aires, Argentina
    Fundacion IDEAA
Jan 2, 2023

Urinary Bladder, Overactive Trial in Denizli (Transcutaneous tibial nerve stimulation (TTNS))

Not yet recruiting
  • Urinary Bladder, Overactive
  • Transcutaneous tibial nerve stimulation (TTNS)
  • Denizli, Turkey
    Pamukkale University
Dec 19, 2022

Healthy Volunteers Trial in Philadelphia (INO-A002, CELLECTRA® 2000, Dengue Fever Antibodies (IgG))

Completed
  • Healthy Volunteers
  • INO-A002
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Nov 7, 2022

Lung Cancer, NSCLC, Brain Metastases Trial (Alectinib, Stereotactic Radiosurgery)

Not yet recruiting
  • Lung Cancer
  • +2 more
  • (no location specified)
Aug 4, 2023

Non-muscle-invasive Bladder Cancer Trial in Zagreb (Gemcitabine 1000 mg, Docetaxel 37.5g)

Active, not recruiting
  • Non-muscle-invasive Bladder Cancer
  • Gemcitabine 1000 mg, Docetaxel 37.5g
  • Zagreb, Croatia
    University Hospital Centre Zagreb
Jan 20, 2023

Malaria Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Pvs230D1-EPA/Matrix-M)

Not yet recruiting
  • Malaria
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 28, 2023

Severe Aplastic Anemia Trial in Tianjin (Hetrombopag Olamine+Standard Therapy, Placebo+Standard Therapy)

Recruiting
  • Severe Aplastic Anemia
  • Hetrombopag Olamine+Standard Therapy
  • Placebo+Standard Therapy
  • Tianjin, Tianjin, China
    Blood Diseases Hospital, Chinese Academy of Medical Sciences
Jul 28, 2022

Non-Muscle- Invasive Bladder Cancer Trial (Durvalumab, BCG)

Not yet recruiting
  • Non-Muscle- Invasive Bladder Cancer
  • Durvalumab
  • BCG
  • (no location specified)
Jul 5, 2023

Helicobacter Pylori Infection Trial in New York (Amoxicillin, Omeprazole, Clarithromycin)

Completed
Has Results
  • Helicobacter Pylori Infection
  • New York, New York
    Mount Sinai Union Square Division of Digestive Diseases
Jan 6, 2023

Metastatic Breast Cancer Trial (Elacestrant)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Oct 24, 2022

Merkel Cell Carcinoma Trial in Milano, Siena, Verona (Pembrolizumab, Etoposide, Cisplatin or Carboplatin)

Not yet recruiting
  • Merkel Cell Carcinoma
  • Pembrolizumab, Etoposide, Cisplatin or Carboplatin
  • Milano, Italy
  • +2 more
Oct 10, 2023

HIV-1-infection Trial (Low-dose STP0404 (Pirmitegravir), Medium-dose STP0404 (Pirmitegravir), High-dose STP0404 (Pirmitegravir))

Not yet recruiting
  • HIV-1-infection
  • Low-dose STP0404 (Pirmitegravir)
  • +3 more
  • (no location specified)
May 16, 2023